Warning
Ascend Laboratories Recalls Amlodipine and Olmesartan Medoxomil Tablets
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0712-2026Drug / Pharmaceutical
Ascend Laboratories Recalls Amlodipine and Olmesartan Medoxomil Tablets
Ascend Laboratories, LLC · Class II — Moderate Risk
Product Description
Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30
Reason for Recall
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide in the USA
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
Ascend Laboratories, LLC has recalled a pharmaceutical product that the FDA classified as Class II affecting 6,192 bottles. The recall was initiated on July 8, 2026. Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications. It was distributed nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medical Product Contamination.